O=C(O)CCN1CC2([N+](=O)[O-])CC=C(OCCO)C([N+](=O)[O-])(C1)C2
Orally active drug usually follows the rule of three, in which the molecular weight of a fragment is <300, the c Log P is ≤3, the number of hydrogen bond donors is ≤3 and the number of hydrogen bond acceptors is ≤3. The molecule meets rule of three or not?